No elevated risk for stroke seen after COVID-19 bivalent vaccine receipt
Mar 20, 2024
No evidence was seen for an increased risk for stroke in one- to 21-day or 22- to 42-day windows compared with a 43- to 90-day window after the vaccine.
Electronic nudge for flu vaccination does not improve clinical outcomes
Mar 19, 2024
No significant difference was seen in hospitalization for pneumonia or influenza or in hospitalization for any cause or mortality.
Many US seniors do not intend to vaccinate against RSV
Mar 13, 2024
The primary reasons for vaccine hesitancy include lack of necessity, concerns about side effects and safety, and lack of information.
COVID-19 vaccination linked to lower risk for postinfection outcomes
Mar 13, 2024
A reduced risk was seen for venous thromboembolism, arterial thrombosis/thromboembolism and heart failure.
Tetanus vaccine may be in short supply after company stops production
Feb 29, 2024
Sanofi plans to ramp up production of its version, but doctors should switch to the Tdap shot in the meantime.
Trust is most important tool in combating ‘infodemic’ surrounding vaccine confidence, expert says
By
Kimberly Bonvissuto
Jan 25, 2024
At the end of the day, building trust is the most important way that providers can combat the “infodemic” surrounding vaccine confidence, according to one public health expert.
Bivalent COVID-19 shot effective for preventing thromboembolic events
Jan 11, 2024
The findings were seen for adults aged 65 years and older and for those aged 18 years and older with end-stage renal disease.
Focus on briefs: Resident security
By
John Hall
Dec 03, 2023
Costs, along with changing attitudes, help fuel growth in deprescribing, Older Americans have access to more vaccines than ever, but increasing numbers cause concern for some individuals
Biden looks to boost supply chain for vaccines and other medicines
By
Kathleen Steele Gaivin
Nov 29, 2023
President Biden on Monday said he plans to use the Defense Production Act to make more “essential medicines” in America in an effort to mitigate drug shortages and curb inflation.
Fourth COVID-19 shot beneficial in patients with autoimmune rheumatic diseases
Nov 28, 2023
A fourth dose reduces the risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs.